By Cecilia Butini 
 

Fresenius SE & Co KGaA said Tuesday that its infusion and transfusion subsidiary Fresenius Kabi AG is expanding its Austrian facilities with an investment of 60 million euros ($72.31 million).

The investment, which will run through 2023, will focus on expanding capacity as well as an upgrade of infrastructure at Fresenius Kabi's production plant in Graz and at a packing center in Werndorf, the company said.

It added that the number of jobs the expansion will create, in addition to the existing 900 in Graz, cannot yet be determined.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

February 09, 2021 05:43 ET (10:43 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Fresenius SE and Company... (PK) 차트를 더 보려면 여기를 클릭.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Fresenius SE and Company... (PK) 차트를 더 보려면 여기를 클릭.